Impact of Covid-19 pandemic on patients with immune thrombocytopaenia
Author
Álvarez Román, María Teresa; Jiménez Yuste, Víctor Manuel; García Barcenilla, Sara; Ramírez López, Andrés; Monzón Manzano, Elena; de la Cruz Benito, Beatriz; Acuña Butta, Paula; Rivas Pollmar, María Isabel; Trelles Martínez, Roberto; González Zorrilla, Elena; Salces, Mónica Martín; Cebanu, Tamara; Butta, Nora V.Entity
UAM. Departamento de Medicina; Instituto de Investigación Sanitaria Hospital Universitario de La Paz (IdiPAZ)Publisher
MDPI, Basel, SwitzerlandDate
2021-03-01Citation
10.3390/medicina57030219
Medicina 57.3 (2021): 219
ISSN
1010-660XDOI
10.3390/medicina57030219Funded by
This study was supported by FIS-Fondos FEDER PI19/00631 and PI19/00772 and by the Platelet Disorder Support AssociationProject
Gobierno de España. PI19/00631; Gobierno de España. PI19/00772Editor's Version
https://doi.org/10.3390/medicina57030219Subjects
COVID-19; Immune thrombocytopaenia; Telemedicine; Vulnerable population; MedicinaRights
© 2021 The authorsAbstract
Background and Objectives: The aim of this study was to determine the impact of the COVID-19 pandemic on the lives of patients with immune thrombocytopaenia (ITP) treated at our hospital. Materials and Methods: The study was conducted in the Community of Madrid, which has the highest number of COVID-19 cases in Spain. We included 143 adult patients with ITP (130 with chronic ITP, 8 with persistent ITP, and 5 with newly diagnosed ITP). We conducted a telephone survey to collect the data and created a registry. Materials and Methods: Overall, 24 patients presented symptoms suggestive of COVID-19, which was confirmed by RT-PCR in 8 cases. The cumulative incidence of confirmed SARS-CoV-2 infection was higher in the patients with ITP than in the Madrid population. There were no differences in the disease incidence or clinical course of infection in the patients treated with immunosuppressants. Almost all of the patients reported adherence to the prescribed treatment, although 49.2% of the hospital visits were either cancelled or postponed, 17.2% because of the patients’ fear of coming to the centre. Nearly half of the cohort was considered vulnerable, and 17% had been granted a dependency or disability benefit. Conclusions: COVID-19 had a major impact on the psychosocial, occupational, and quality of care of patients with ITP.
Files in this item
Google Scholar:Álvarez Román, María Teresa
-
Jiménez Yuste, Víctor Manuel
-
García Barcenilla, Sara
-
Ramírez López, Andrés
-
Monzón Manzano, Elena
-
de la Cruz Benito, Beatriz
-
Acuña Butta, Paula
-
Rivas Pollmar, María Isabel
-
Trelles Martínez, Roberto
-
González Zorrilla, Elena
-
Salces, Mónica Martín
-
Cebanu, Tamara
-
Butta, Nora V.
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
The importance of platelet glycoside residues in the haemostasis of patients with immune thrombocytopaenia
Ramírez-López, Andrés; Álvarez Román, María Teresa; Monzón Manzano, Elena; Acuña, Paula; Arias-Salgado, Elena G.; Martín Salces, Mónica; Rivas Pollmar, María Isabel; Jiménez Yuste, Víctor Manuel; Sanz, Raul Justo; García Barcenilla, Sara; Cebanu, Tamara; González Zorrilla, Elena; Butta, Nora V.
2021-04-13